Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Public Health / 公共衛生學院
  3. Epidemiology and Preventive Medicine / 流行病學與預防醫學研究所
  4. Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): A case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence
 
  • Details

Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): A case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence

Resource
BMC Cardiovasc. Disord., 12
Journal
BMC Cardiovascular Disorders
Journal Volume
12
Pages
4
Date Issued
2012
Date
2012
Author(s)
Shau, Wen-Yi
Chen, Hsi-Chieh
Chen, Shu-Ting
Chou, Hsu-Wen
CHIA-HSUIN CHANG  
Kuo, Chuei-Wen
Lai, Mei-Shu
DOI
10.1186/1471-2261-12-4
URI
http://ntur.lib.ntu.edu.tw//handle/246246/258748
http://ntur.lib.ntu.edu.tw/bitstream/246246/258748/1/index.html
Abstract
Background: Previous studies have documented the increased cardiovascular risk associated with the use of some nonsteroidal anti-inflammatory drugs (NSAIDs). Despite this, many old NSAIDs are still prescribed worldwide. Most of the studies to date have been focused on specific oral drugs or limited by the number of cases examined. We studied the risk of new acute myocardial infarction (AMI) hospitalization with current use of a variety of oral and parenteral NSAIDs in a nationwide population, and compared our results with existing evidence. Methods: We conducted a case-crossover study using the Taiwan's National Health Insurance claim database, identifying patients with new AMI hospitalized in 2006. The 1-30 days and 91-120 days prior to the admission were defined as case and matched control period for each patient, respectively. Uses of NSAIDs during the respective periods were compared using conditional logistic regression and adjusted for use of co-medications. Results: 8354 new AMI hospitalization patients fulfilled the study criteria. 14 oral and 3 parenteral NSAIDs were selected based on drug utilization profile among 13.7 million NSAID users. The adjusted odds ratio, aOR (95% confidence interval), for risk of AMI and use of oral and parenteral non-selective NSAIDs were 1.42 (1.29, 1.56) and 3.35 (2.50, 4.47), respectively, and significantly greater for parenteral than oral drugs (p for interaction < 0.01). Ketorolac was associated with the highest AMI risk among both of oral and parenteral NSAIDs studied, the aORs were 2.02 (1.00, 4.09) and 4.27 (2.90, 6.29) respectively. Use of oral flurbiprofen, ibuprofen, sulindac, diclofenac, and parenteral ketoprofen were also significantly associated with increased AMI risk. The results of the present study were consistent with the majority of evidence from previous studies. Conclusions: The collective evidence revealed the tendency of increased AMI risk with current use of some NSAIDs. A higher AMI risk associated with use of parenteral NSAIDs was observed in the present study. Ketorolac had the highest associated risk in both oral and parenteral NSAIDs studied. Though further investigation to confirm the association is warranted, prescribing physicians and the general public should be cautious about the potential risk of AMI when using NSAIDs.
SDGs

[SDGs]SDG3

Other Subjects
2,4 thiazolidinedione derivative; acemetacin; acetylsalicylic acid; antihypertensive agent; antithrombocytic agent; antivitamin K; beta adrenergic receptor blocking agent; calcium channel blocking agent; celecoxib; diclofenac; dipeptidyl carboxypeptidase inhibitor; flurbiprofen; hydroxymethylglutaryl coenzyme A reductase inhibitor; ibuprofen; indometacin; insulin; ketoprofen; ketorolac; loop diuretic agent; mefenamic acid; meloxicam; naproxen; nonsteroid antiinflammatory agent; piroxicam; sulfonylurea; sulindac; nonsteroid antiinflammatory agent; prostaglandin synthase inhibitor; acute heart infarction; adult; article; cardiovascular risk; controlled study; crossover procedure; disease association; drug use; female; hospitalization; human; length of stay; male; national health insurance; outpatient; priority journal; risk assessment; risk factor; aged; factual database; heart infarction; middle aged; oral drug administration; risk; Taiwan; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Databases, Factual; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Risk Factors; Taiwan
Type
journal article
File(s)
Loading...
Thumbnail Image
Name

index.html

Size

23.16 KB

Format

HTML

Checksum

(MD5):72dbbf951774a5d80d850fd2ad981477

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science